Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEAL Study in Hypertension
NCT00128518Phase 4Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2004
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of perindopril and indapamide in hypertension (HTN) (4 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Blood pressure at 16 weeks. Started Oct 2004; status: completed.
02
Drugs
perindoprilindapamide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00128518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128518.